Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7944 results

Sort By:

Caris Biorepository Research Protocol

Study ID: NCT01499394
Start Date: 2010-11
End Date: 2025-11
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

100000

Intervention / Treatment
Sponsor

Caris Science, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations

Study ID: NCT04550494
Start Date: 2021-04-26
End Date: 2026-12-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

36

Intervention / Treatment

Biopsy Procedure

Biospecimen Collection

Computed Tomography

Magnetic Resonance Imaging

Carcolor

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

HPV Multilevel Intervention Strategies Targeting Immunization in Community Settings (HPV MISTICS)

Study ID: NCT05677360
Start Date: 2023-01-09
End Date: 2026-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

564

Intervention / Treatment

HPV MISTICS -Provider Level

HPV MISTICS - Parent Level

HPV MISTICS- HPV Vaccine Champion Level

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Source: clinicaltrials.gov

Share:
Add to list

Single Cell Immune and Non-immune Correlates of Response to Neoadjuvant Abemaciclib

Study ID: NCT04614194
Start Date: 2021-04-15
End Date: 2028-04-15
Study Type

Interventional

Study Phase

Phase2

No. of Participants

60

Intervention / Treatment

Letrozole

Abemaciclib

Sponsor

University of Texas Southwestern Medical Center

Source: clinicaltrials.gov

Share:
Add to list

A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials

Study ID: NCT05655494
Start Date: 2025-04-01
End Date: 2027-08-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

350

Intervention / Treatment

Stand-alone Research Portal

Portal with Virtual Community Health Educator (vCHE)

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

Defining Inflammatory Markers of Cardiovascular Disease in Patients With Myelodysplastic Syndromes

Study ID: NCT06692894
Start Date: 2024-11-05
End Date: 2027-11
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Observational

Sponsor

University of Vermont

Source: clinicaltrials.gov

Share:
Add to list

Pre-malignant States to Hematologic Malignancies in Firefighters

Study ID: NCT06870760
Start Date: 2025-06
End Date: 2027-04
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

300

Intervention / Treatment

Monoclonal Gammopathy

Complete Blood Count with differential (CBC w/ diff)

Clonal hematopoiesis (CHIP)

Sponsor

Wake Forest University Health Sciences

Source: clinicaltrials.gov

Share:
Add to list

Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer

Study ID: NCT05020860
Start Date: 2023-04-18
End Date: 2029-11
Study Type

Interventional

Study Phase

Phase2

No. of Participants

185

Intervention / Treatment

Paclitaxel

Carboplatin

Trastuzumab

Pertuzumab

Doxorubicin

Cyclophosphamide

Pembrolizumab

Pertuzumab/Trastuzumab/Hyaluronidase-zzxf

Sponsor

Baylor Breast Care Center

Source: clinicaltrials.gov

Share:
Add to list

Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer

Study ID: NCT05941520
Start Date: 2024-08-23
End Date: 2028-09-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

80

Intervention / Treatment

Acolbifene Hydrochloride

Biospecimen Collection

Mammography

Administration questionnaire

Random Periareolar Fine-Needle Aspiration

Ta grinding powder

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Apricity CARE to Improve ICI Outcomes of Ethnic/Racial Minority NSCLC Patients

Study ID: NCT05812274
Start Date: 2023-04
End Date: 2025-08
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

280

Intervention / Treatment

Apricity C.A.R.E. Program for Cancer Adverse events Rapid Evaluation

Sponsor

Columbia University

Source: clinicaltrials.gov

Share:
Add to list